During the past decade, Department of infectious diseases conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Department of infectious diseases" #1 collaborator was "Karolinska Institutet" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Department of infectious diseases" are "Exposed to TBE-virus" (1 trials), "Immunosuppression" (1 trials), "Response to Hepatitis A Vaccine" (1 trials), "Rheumatoid Arthritis" (1 trials) and "Tick-borne Encephalitis" (1 trials). Many other conditions were trialed in "Department of infectious diseases" in a lesser frequency.

Most popular intervention types in "Department of infectious diseases" are "Biological" (4 trials). Other intervention types were less common.

The name of intervention was led by "FSME-immune" (1 trials), "TBE-vaccine" (1 trials), "Vaccination against TBE" (1 trials), "hepatitis A vaccine" (1 trials) and "hepatitis A vaccine ( HAVRIX or EPAXAL)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Department of infectious diseases" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Department of infectious diseases". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Department of infectious diseases, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Department of infectious diseases, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".